HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery.

Abstract
The study was aimed at determining the vascular expression of oncofetal fibronectin (oncfFn) and tenascin-C (oncfTn-C) isoforms in renal cell carcinoma (RCC) and its metastases which are well-known targets for antibody-based pharmacodelivery. Furthermore, the influence of tumour cells on endothelial mRNA expression of these molecules was investigated. Evaluation of vascular ED-A(+) and ED-B(+) Fn as well as A1(+) and C(+) Tn-C was performed after immunofluorescence double and triple staining using human recombinant antibodies on clear cell, papillary and chromophobe primary RCC and metastases. The influence of hypoxic RCC-conditioned medium on oncfFn and oncfTn-C mRNA expression was examined in human umbilical vein endothelial cells (HUVEC) by real time RT-PCR. There are RCC subtype specific expression profiles of vascular oncfFn and oncfTn-C and corresponding patterns when comparing primary tumours and metastases. Within one tumour, there are different vessel populations with regard to the incorporation of oncfTn-C and oncfFn into the vessel wall. In vitro tumour-derived soluble mediators induce an up regulation of oncfTn-C and oncfFn mRNA in HUVEC which can be blocked by Avastin(®). Vascular expression of oncFn and oncTn-C variants depends on RCC subtype and may reflect an individual tumour stroma interaction or different stages of vessel development. Therefore, oncFn or oncTn-C variants can be suggested as molecular targets for individualized antibody based therapy strategies in RCC. Tumour-derived VEGF could be shown to regulate target expression.
AuthorsKerstin Galler, Kerstin Junker, Marcus Franz, Julia Hentschel, Petra Richter, Mieczyslaw Gajda, Angela Göhlert, Ferdinand von Eggeling, Regine Heller, Raffaella Giavazzi, Dario Neri, Hartwig Kosmehl, Heiko Wunderlich, Alexander Berndt
JournalHistochemistry and cell biology (Histochem Cell Biol) Vol. 137 Issue 2 Pg. 195-204 (Feb 2012) ISSN: 1432-119X [Electronic] Germany
PMID22075565 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibronectins
  • Protein Isoforms
  • RNA, Messenger
  • Tenascin
  • Vascular Endothelial Growth Factor A
Topics
  • Adenocarcinoma, Clear Cell (blood supply, pathology, secondary)
  • Animals
  • Blood Vessels (metabolism, pathology)
  • Carcinoma, Papillary (blood supply, pathology, secondary)
  • Carcinoma, Renal Cell (blood supply, pathology, secondary)
  • Female
  • Fibronectins (metabolism)
  • Human Umbilical Vein Endothelial Cells (metabolism)
  • Humans
  • Kidney Neoplasms (blood supply, pathology, secondary)
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic
  • Protein Isoforms (metabolism)
  • RNA, Messenger (metabolism)
  • Tenascin (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: